Dickon Hayne

17PUBLICATIONS
23CO-AUTHORS
Biomedical imagingCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMajor global burdens of diseasePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 12, 2026
SUBDUE-3: SUB-urothelial DUrvalumab-<sup>89</sup>zirconium injEction; a phase 0 biodistribution study protocol.

Kevin G Keane, Richard Gauci, Roslyn J Francis

|Oct 28, 2025
G-DISCO: Gemcitabine-Docetaxel Intravesical Synchronous CO-administration - a phase 1 study protocol.

Kevin G Keane, Cynthia Hawks, Steve P McCombie

|Jan 25, 2025
Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions.

Sam McDonald, Kevin G Keane, Richard Gauci

|Nov 22, 2024
Hypervirulent Klebsiella pneumoniae causing emphysematous pyelonephritis: a life-threatening pathogen within Australian communities.

Katherine Gc Ong, John R Dyer, Dickon Hayne

|Oct 16, 2024
Development of a new radical cystectomy surveillance protocol and nurse-led cystectomy follow-up clinic in Australia.

Ashley Lee, Katherine Ong, Mohammed Al-Zubaidi

|Mar 12, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer.

Dickon Hayne, Katherine Ong, Nicole Swarbrick

Pageof 3

Frequent Collaborators

9 joint publications

Cynthia Hawks

4 joint publications

Pravin Viswambaram

2 joint publications

Steve P McCombie

1 joint publications

Bradley R Reynolds